The Winship Cancer Institute of Emory University offers the most advanced, specialized care found anywhere for a patient with pleural mesothelioma.
About Winship Cancer Institute
Winship takes its leadership role seriously by providing world-class clinical care fueled by its own groundbreaking research and discoveries.
It is the only National Cancer Institute Comprehensive Cancer Center in Georgia.
Winship has a multidisciplinary cancer care program that offers chemotherapy, radiation, proton therapy, surgery, immunotherapy and state-of-the-art targeted therapy for patients with mesothelioma. It also offers a wide range of complementary therapies and helpful social services.
Personalized treatment plans at Winship are formulated by a diverse staff, which combines traditional diagnostics and staging along with molecular screening and tumor genetics.
The medical center treats more than 17,000 patients from throughout the state and across the Southeast each year.
Winship prides itself on promoting core values that include integrity, innovation, collaboration, courage, compassion and hope.
A Team of Experts
- Dr. Rathi Pillai, the medical oncologist whose research efforts center around clinical trials.
- Dr. Suresh Ramalingam, Division of Medical Oncology director. He also is the lead of Winship’s Discovery & Developmental Therapeutics Program.
- Dr. Seth Force, surgical director of Thoracic Oncology. He also is head of the Adult Lung Transplant Program at Winship.
- Dr. Dong M. Shin, medical oncologist who has helped develop targeted therapy that relies on specific biomarkers.
U.S. News & World Report lists Winship as one of the country’s leading cancer programs. Its nurses also have earned the prestigious Magnet recognition for nursing excellence.
Research Excellence at Winship
The research staff at Winship was part of 250 different clinical trials that included more than 700 patients in 2017.
Winship was one of 30 cancer centers within the U.S. originally selected as a Lead Academic Participating Site for the National Clinical Trials Network.
Winship received more than $85.7 million in research funding in 2016, including $38.6 million from the National Cancer Institute.
Its physicians see patients at Emory University Hospital, Emory Johns Creek Hospital, Emory Saint Joseph’s Hospital, the Atlanta VA Medical Center and Aflac Cancer and Blood Disorders Center.
Cancer patients at Winship often live longer, better lives because of the biomedical research being done close to home, relying on the latest precision medicine.
There is a strong emphasis on early lung cancer screening, designed to spot disease when it is most treatable.
Winship offers lung-computed tomography (CT screening), which includes low-dose radiation for patients with history of tobacco use.